Prospecto: information for the user
Tyverb 250mg film-coated tablets
lapatinib
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1.What isTyverband what it is used for
2.What you need to know before starting to takeTyverb
3.How to takeTyverb
4.Possible adverse effects
5Storage ofTyverb
6.Contents of the pack and additional information
Tyverb is used to treat some types of breast cancerthat overexpress HER2 receptors and have spread beyond the original tumor or to other organs (advanced or metastatic breast cancer). This medication may reduce or stop the growth of cancer cells, or eliminate them.
Tyverb is prescribed to be taken in combination with other anticancer medications.
Tyverb is prescribed in combination with capecitabinain patients who have received previous treatment for advanced or metastatic breast cancer. The previous treatment for metastatic breast cancer must have included trastuzumab.
Tyverb is prescribed in combination with trastuzumabin patients with metastatic breast cancer that is hormone receptor-negative and who have received previous treatment for metastatic breast cancer.
Tyverb is prescribed in combination with an aromatase inhibitorin patients with hormone-sensitive metastatic breast cancer (breast cancer that is more likely to grow in the presence of hormones), for whom chemotherapy is not suitable.
The information for these medications is described in separate prospectuses.Ask your doctor to provide you with the information for these medications.
Do not take Tyverb
Be especially careful with Tyverb
Your doctor will perform tests to check that your heart is working correctlybefore and during treatment with Tyverb.
Before taking Tyverb,inform your doctor if you have any heart problems.
Before starting to take Tyverb, your doctor also needs to know:
Your doctor will perform tests to check that your liver is working correctlybefore and during treatment with Tyverb.
Inform your doctorif you are in any of these situations.
Severe skin reactions
Severe skin reactions have been observed with the use of Tyverb. Symptoms may include skin rash, blisters, and skin peeling.
Informyour doctor as soon as possible if you experience any of these symptoms.
Other medicines and Tyverb
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.Also included are herbal remedies and other medicines obtained without a prescription.
It is especially important that you inform your doctorif you are using or have used recently any of the following medicines. Some medicines may affect how Tyverb works or Tyverb may affect how other medicines work. These medicines include medicines in the following groups:
Inform your doctorif you are using or have used recently any of these medicines.
Your doctor will review the medicines you are taking to ensure that you are not taking any medicine that cannot be taken with Tyverb. Your doctor will advise you if there is any alternative available.
Taking Tyverb with food and drinks
Do not drink grapefruit juice whileyou are being treated with Tyverb. It may affect how this medicine works.
Pregnancy and breastfeeding
The effect of Tyverb during pregnancy is unknown. Do not use Tyverb if you are pregnant, unless your doctor specifically recommends it.
The effect of Tyverb on breast milk is unknown. Do not breastfeed while taking Tyverb and for at least 5 days after the last dose.
If you have any doubts, ask yourdoctor or pharmacistbefore taking Tyverb.
Driving and operating machinery
You are responsible for deciding if you are able to drive a vehicle or perform tasks that require high concentration. Due to the possible side effects of Tyverb, your ability to drive or operate machinery may be affected. These side effects are described in section 4, “Possible side effects”.
Tyverb contains sodium
This medicine contains less than 1mmol of sodium (23mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor.If in doubt, consult your doctor or pharmacist again.
Your doctor will decide on the appropriate dose of Tyverb depending on the type of breast cancer you are being treated for.
If you are prescribed Tyverb incombination with capecitabina, the usual dose is5 Tyverb tablets per day, in a single dose.
If you are prescribed Tyverb incombination with trastuzumab, the usual dose is4 Tyverb tablets per day, in a single dose.
If you are prescribed Tyverb incombination with an aromatase inhibitor, the usual dose is6 Tyverb tablets per day, in a single dose.
Take the dose prescribed by your doctor every day for the time they indicate.
Your doctor will inform you about the dose of the other anticancer medication, and how to take it.
Tablet Taking
While Taking Tyverb
If You Take More Tyverb Than You Should
Immediately contact your doctor or pharmacist. If possible, show them the packaging.
If You Forget to Take Tyverb
Do not take a double doseto make up for the missed doses. Take the next dose at the scheduled time.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
A severe allergic reaction is a rare side effect that can affect up to 1 in 1,000 people and can appear quickly.
The symptoms may include:
Inform your doctor immediately if you have any of these symptoms. Do not take more tablets.
Very common side effects (may affect more than 1 in 10 people)
Inform your doctor immediately at the first sign of diarrhea, as it is very important that diarrhea is treated immediately. Also, inform your doctor immediately if diarrhea worsens.You can find more advice on how to reduce the risk of diarrhea at the end of section 4.
Inform your doctor if you have a skin rash.You can find more advice on how to reduce the risk of skin rash in section 4.
Other very common side effects:
Inform your doctor if any of these side effects become severe or problematic.
Common side effects (may affect up to 1 in 10 people):
In most cases, the effect on your heart will have no symptoms. If you experience symptoms associated with this side effect, these may include irregular heartbeat and difficult breathing.
Inform your doctor if you have any of these symptoms.
Rare side effects (may affect up to 1 in 1,000 people):
Inform your doctor immediately if you have any of these symptoms.
Other rare side effects include:
Unknown frequency (cannot be estimated from available data):
If you have any other side effects
Inform your doctor or pharmacist, if you notice any side effects not mentioned in this leaflet..
Reducing the risk of diarrhea and skin rash
Tyverb may cause severe diarrhea
If you experience diarrhea while taking Tyverb:
Inform your doctor if your diarrhea continues.
Tyverb may cause skin rash
Your doctor will perform skin checks before and during treatment.
To care for sensitive skin:
Inform your doctor if you have a skin rash.
Reporting side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect that does not appear in this leaflet.Also, you can report them directly through thenational reporting system included in theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack or bottle and in the carton.
Do not store at a temperature above30°C.
Dispose of unused medications and packaging through your pharmacist. This will help protect the environment.
Composition of Tyverb
Appearance of the product and contents of the pack
Tyverb film-coated tablets are oval, biconvex, yellow, film-coated, with "GS XJG" engraved on one side.
Tyverb is supplied in blister packs or bottles:
Blister packs
Each pack of Tyverb contains 70 or 84 film-coated tablets in an aluminium blister pack of 10 or 12 tablets. Each blister has a perforation in the middle that allows these to be divided into two blisters of 5 or 6 tablets, depending on the pack size.
Tyverb is also available in multiple packs with 140 tablets, which contain 2 packs of 70 tablets.
Bottles
Tyverb is also available in plastic bottles containing 70, 84, 105, or 140 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Responsible for manufacturing
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana
Slovenia
Novartis Pharmaceutical Manufacturing LLC
Verovškova ulica 57
1000 Ljubljana
Slovenia
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Glaxo Wellcome, S.A.
Avda.Extremadura, 3
09400 Aranda de Duero, Burgos
Spain
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Sandoz S.R.L.
Str. Livezeni nr. 7A
540472 Targu Mures
Romania
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
For further information about this medicinal product, please consult the representative of the marketing authorisation holder in your country:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 88 04 52 555 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Εlláδα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358 (0)10 6133 200 |
Κúpρος Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija SIA Novartis Baltics Tel: +371 67 887 070 |
Last update of the summary of product characteristics:
The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.